Position in DARE
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$211
+$181 QoQ
Shares Held
100
+488.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#25
of 27 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in DARE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CALDWELL SUTTER CAPITAL, INC. holds $550,133 across 24 Biotechnology names. DARE ranks #19 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
|
2,000 | $148,960 | |
| 2 | INSM |
INSMED Inc
|
727 | $77,512 | |
| 3 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
118 | $63,360 | |
| 4 | ASND |
Ascendis Pharma A/S
|
218 | $58,144 | |
| 5 | IDYA |
IDEAYA Biosciences, Inc.
|
1,554 | $57,917 | |
| 6 | TVTX |
Travere Therapeutics, Inc.
|
693 | $39,369 | |
| 7 | PCVX |
Vaxcyte, Inc.
|
432 | $25,112 | |
| 8 | 626 | $23,424 |
All Filings in DARE
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $211 | 100 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $30 | 17 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $32 | 17 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $35 | 17 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $40 | 17 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $49 | 17 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $53 | 17 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $55 | 17 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $67 | 200 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 | $97 | 200 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $61 | 200 | Shares | Sole | 2024-01-19 | |
| 2023-09-30 | $92 | 200 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $181 | 200 | Shares | Sole | 2023-07-19 | |
| No filing history on record for this holder in this stock. | ||||||